Anastasis Nikolaou is 10% at Acrivon Therapeutics, Inc. (ACRV). They have made 1 open-market trade across 1 company since 2023, most recently 2023-06-15.
CIK 0001954186
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACRV | 3,848,648 | $6.3M |
Shares reported on the most recent Form 4, priced at the 2023-06-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACRV | SELL | 2023-06-15 | 2023-06-20 | $12.14 | $25K | +0.9% | +1.6% | -21.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.